Mar 20 0 Sound Pharmaceuticals announces completion of patient enrollment in the Phase 2b Meniere’s Disease clinical trial By Jim | News Short | No Comments Read More
Jan 14 0 Sound Pharmaceuticals advances Phase 2 hearing loss clinical trial in Cystic Fibrosis By Jim | News Short | No Comments Read More
Oct 18 0 Sound Pharmaceuticals to Present Preliminary Data on Ototoxicity Study By Jim | News Short | No Comments Read More
Nov 01 0 University of Oxford and Sound Pharmaceuticals begin Phase 2 clinical trial on novel treatment for bipolar disorder By Jim | News Short | No Comments Read More
Oct 03 0 Sound Pharmaceuticals announces positive Phase 1b results and the start of a Phase 2b clinical trial in Meniere’s Disease By Jim | News Short | No Comments Read More
Sep 29 0 Enrollment Underway in CF Clinical Trial for Ear Toxicity Caused by Antibiotics By Jim | News Short | No Comments Read More
Jun 29 0 Sound Pharmaceuticals completes enrollment on Meniere’s Disease clinical trial By Jim | News Short | No Comments Read More
Mar 20 0 Sound Pharmaceuticals announces $1.6 Million Award from Cystic Fibrosis Foundation Therapeutics to prevent and treat the hearing loss and tinnitus associated with antibiotic use By Jim | News Short | No Comments Read More
Nov 01 0 Sound Pharmaceuticals announces two new executive hires to accelerate its Meniere’s drug development program By Jim | News Short | No Comments Read More
Sep 07 0 Sound Pharmaceuticals and DoD collaborate on new hearing loss guidance By Jim | News Short | No Comments Seattle, WA Read More
